TITLE

Letter: Continuous insulin infusion

AUTHOR(S)
Pfeiffer, E F; Thum, C; Clemens, A H
PUB. DATE
September 1974
SOURCE
British Medical Journal;9/7/1974, Vol. 3 Issue 5931, p626
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64111671

 

Related Articles

  • Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections: The Impact of Baseline A1c. Blumer, Ian // Diabetes Care;Mar2005, Vol. 28 Issue 3, p763 

    Presents a letter to the editor in response to an article regarding continuous subcutaneous insulin infusion therapy and multiple daily insulin injection.

  • Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections: The Impact of Baseline A1c. Retnakaran, Ravi; Zinman, Bernard // Diabetes Care;Mar2005, Vol. 28 Issue 3, p763 

    Presents a letter to the editor in response to an article on continuous subcutaneous insulin infusion therapy and multiple daily insulin injection.

  • A Comparison of Basal Insulin Delivery. King, Allen B.; Armstrong, Dana // Diabetes Care;Apr2003, Vol. 26 Issue 4, p1322 

    Presents a letter to the editor on the use of continuous subcutaneous insulin infusion versus glargine to treat diabetes.

  • continuous subcutaneous insulin infusion.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p515 

    An encyclopedia entry for "continuous subcutaneous insulin infusion" is presented.

  • Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII). Reichel, A.; Schwarz, J.; Schulze, J.; Licinio, J.; Wong, M.-L.; Bornstein, S. R. // Molecular Psychiatry;Nov2005, Vol. 10 Issue 11, p975 

    Presents a letter to the editor in response to the article "Depression and Anxiety Symptoms in Diabetic Patients on Continuous Subcutaneous Insulin Infusion (CSII)," published in previous issue.

  • A case of lipoatrophy with Lispro insulin without insulin pump therapy. Arranz, Alfonso; Andia, Victor; López-Guzmán, Antonio; López-Guzmán, Antonio // Diabetes Care;Feb2004, Vol. 27 Issue 2, p625 

    Presents a letter to the editor regarding a case of localized lipoatrophy associated with treatment with Lispo insulin administered in a multiple dose regimen that disregards the role of continuous subcutaneous insulin infusion as a necessary factor for its genesis.

  • Subcutaneous continuous insulin infusion and control of blood glucose concentration in diabetics in third trimester of pregnancy. Potter, Jonathan M.; Reckless, John P.D.; Cullen, Derek R. // British Medical Journal;4/26/1980, Vol. 280 Issue 6222, p1099 

    Investigates the effect of subcutaneous continuous insulin infusion on blood glucose concentration regulation. Administration of subcutaneous insulin in pregnant diabetics; Benefits of subcutaneous insulin infusion; Comparison between continuous and conventional insulin infusion.

  • CLINICAL THERAPEUTICS/NEW TECHNOLOGY--INSULIN DELIVERY SYSTEMS.  // Diabetes;Jun2008 Supplement 1, Vol. 57, pA556 

    The article presents abstracts of topics about insulin delivery systems, which include continuous subcutaneous insulin infusion (CSII), insulin pump therapy and insulin injections.

  • Letters. Saunders, Patrick; Rouse, Andrew; Ali, Shaukat; Dettwyler, Katherine A; Holmes, Wendy; Greiner, Ted; Sikorski, Jim; Dezateux, Carol; Holt, Anne; Wilkinson, Ian B; Cockcroft, John R; Dark, Paul Michael; Rölli, Marie-Josée; Leeson, Paul; Lucas, Alan; Davies, Sharon; Gøtzsche, Peter C; Knight, G; Oko, Michael // BMJ: British Medical Journal (International Edition);9/22/2001, Vol. 323 Issue 7314, p689 

    Presents letters to the editor concerning medical issues. Disposal of mercury sphygmomanometers; Duration of breast feeding and adult arterial distensibility; Risks with continuous subcutaneous insulin infusion; Others.

  • Insulin pumps: more consultation was needed. Palmer, Andrew J.; Tucker, Daniel M. D.; Ray, Joshua A.; Valentine, William J.; Currie, Craig; McEwan, Phil; Brändle, Michael // BMJ: British Medical Journal (International Edition);10/15/2005, Vol. 331 Issue 7521, p905 

    Presents a letter to the editor that criticizes a health technology assessment published by Colquitt and colleagues on the effectiveness of continuous subcutaneous insulin infusion and mentions the National Institute for Health and Clinical Excellence (NICE).

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics